ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

ALKS vs ABVX // OPTIONS IMPLIED MOVE & PUT/CALL SKEW

Alkermes plc (NASDAQ) VS. Abivax SA (NASDAQ) • 15-METRIC TALLY: ALKS 8 — ABVX 3
■ METRIC PARITY
options-implied-move
—
options-implied-move
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ALKS VS. ABVX) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC ALKS ABVX SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 86.70% — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) 14.00% 9.90% +4.10 ALKS /roic <GO>
EV/EBITDA & P/E Valuation 25.1x 21.0x +4.10 ABVX /valuation <GO>
Free Cash Flow Yield 6.31% 2.21% +4.10 ALKS /fcf-yield <GO>
Operating Margin 17.20% 13.90% +3.30 ALKS /operating-margins <GO>
Net Profit Margin 16.40% 10.90% +5.50 ALKS /net-margins <GO>
Revenue Growth (YoY) -5.20% 8.80% -14.00 ABVX /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 8.03 3.74 +4.29 ALKS /balance-sheet <GO>
Piotroski F-Score Quality 7/9 8/9 -1.00 ABVX /piotroski-score <GO>
Options Implied Move & Put/Call Skew ACTIVE — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 57.3 38.7 +18.60 ALKS /rsi-technicals <GO>
10Y Yield & FRED Macro Beta 1.05 1.05 0.00 TIE /macro-sensitivity <GO>
Forward P/E Multiple 29.3x 30.5x -1.20 ALKS /forward-pe <GO>
Enterprise Scale & Market Cap $7.53B $7.41B $122.2M ALKS /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR ALKS REV ABVX REV ALKS GROSS % ABVX GROSS % ALKS FCF ABVX FCF
FY 2025 $1.48B — 86.7% — $480.3M —
FY 2024 $1.56B — 84.2% — $405.6M —
FY 2023 $1.66B — — — $326.5M —
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ALKS // BETA 1.05
ABVX // BETA 1.05